Genscript Biotech Corporation
Status: Publicly traded
Direct answer
Genscript Biotech Corporation is publicly traded on HKSE under the ticker 1548.HK.
Operating as an investment holding company, Genscript Biotech Corporation, established in 2002 and headquartered in Nanjing, People's Republic of China, specializes in the global provision of innovative life science research solutions, encompassing both products and services. Its market presence spans North America, Europe, China, Japan, other Asia Pacific regions, and numerous international markets. The enterprise...
Can you invest in Genscript Biotech Corporation?
Yes. Genscript Biotech Corporation trades publicly on HKSE as 1548.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Genscript Biotech Corporation
Detailed equity research is provided by MarketSnap.